New peri-op approach accurately IDs melanoma in nail matrix

New peri-Op approach accurately IDs melanoma in nail matrix
Intraoperative reflectance confocal microscopy can be used to diagnose melanonychia striata in the nail matrix, according to a study published online June 7 in the British Journal of Dermatology.

(HealthDay) -- Intraoperative reflectance confocal microscopy (RCM) can be used to diagnose melanonychia striata in the nail matrix, according to a study published online June 7 in the British Journal of Dermatology.

Sébastien Debarbieux, M.D., of the Centre Hospitalier Lyon Sud in Pierre Bénite, France, and colleagues assessed the feasibility of intraoperative of melanonychia striata in a series of nine patients who underwent a matricial biopsy for an acquired melanonychia (one benign lentigo, eight melanomas). RCM examination was performed in vivo and/or ex vivo.

The researchers found that confocal and histopathological features correlated well. Confocal features were used for unequivocal intraoperative diagnosis of seven of the cases, and RCM correctly classified the lentigo as benign. RCM did not provide a definite classification for the last lesion, which corresponded histopathologically to an early melanoma.

"Intraoperative RCM examination of the nail matrix is an efficient diagnostic approach of melanonychia striata that permits an extemporaneous diagnosis of malignancy and therefore a one-step surgical treatment of in situ or minimally invasive melanoma, reducing dramatically the duration of postoperative disability," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Melanomas may appear noticeably different than other moles

date Jan 21, 2008

A preliminary study suggests that melanomas have a different appearance than other irregular skin moles (i.e., are “ugly ducklings”), according to a report in the January issue of Archives of Dermatology, one of the JAMA/Archives ...

Recommended for you

New drug for neuroblastoma shows promise in phase I study

date 16 hours ago

Researchers at Spectrum Health Helen DeVos Children's Hospital have completed the first clinical trial of a new treatment for children suffering from neuroblastoma. In a clinical trial led by Giselle Sholler, MD, pediatri ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.